SOSI research
This article was originally published in The Rose Sheet
Executive Summary
Loss of the sense of smell results in corresponding loss of quality of life, researchers at the University of Dresden Medical School report in white paper commissioned by the Sense of Smell Institute. It is estimated that a complete loss of the sense of smell is found in at least 1% of the U.S. population, while in a study of individuals aged 53-97, nearly one-fourth were found to have an impaired sense of smell, white paper reports. Other than aging, head injury and sino-nasal disease are the primary causes of loss of smell...
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.